Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyophilized Plasma in Acquired Coagulopathy Due to Liver Disease
NCT01547078Phase 2Withdrawn
- Sponsor
- Tricol Biomedical
- Start
- Jan 2015
- Primary completion
- Jan 2016
- Modality
- Biologic, Plasma product
01
Overview
Phase 2, randomised trial of dried plasma in Acquired coagulopathy (2 arms), sponsored by Tricol Biomedical. Primary endpoint: Adverse Events up to 7 days. Planned start Jan 2015; status: withdrawn.
02
Drugs
dried plasma
03
Conditions
Acquired coagulopathy
Beyond the preview
Go deeper on NCT01547078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01547078.